Masaru Furukawa received his M.D. from Hiroshima University in 2015, and subsequently earned his Ph.D. in Medicine from Hiroshima University. He has been working as a clinical physician at Hiroshima University Hospital since 2020. His research topics mainly include pancreatic and biliary diseases, with a particular focus on IgG4-related sclerosing cholangitis and biliary stenting for pancreatic cancer, as well as clinical outcomes, endoscopic management, and chemotherapy.
Masaru Furukawa received his M.D. from Hiroshima University in 2015, and subsequently earned his Ph.D. in Medicine from Hiroshima University. He has been working as a clinical physician at Hiroshima University Hospital since 2020. His research topics mainly include pancreatic and biliary diseases, with a particular focus on IgG4-related sclerosing cholangitis and biliary stenting for pancreatic cancer, as well as clinical outcomes, endoscopic management, and chemotherapy.